CIRUGÍA
Département
![Foto de Alfredo](/img/nophoto.png)
Alfredo
Carrato Mena
Publications dans lesquelles il/elle collabore avec Alfredo Carrato Mena (9)
2021
-
A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer
Genome Medicine, Vol. 13, Núm. 1
-
Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses
Gut, Vol. 70, Núm. 2, pp. 319-329
-
Gallbladder disease and pancreatic cancer risk: a multicentric case-control European study
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), Vol. 30, Núm. 6, pp. 423-430
2020
-
Pancreatic Cancer Risk in Relation to Lifetime Smoking Patterns, Tobacco Type, and Dose-Response Relationships
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, Vol. 29, Núm. 5, pp. 1009-1018
2019
-
Pancreatic cancer and autoimmune diseases: An association sustained by computational and epidemiological case–control approaches
International Journal of Cancer, Vol. 144, Núm. 7, pp. 1540-1549
2018
-
Risk of pancreatic cancer associated with family history of cancer and other medical conditions by accounting for smoking among relatives
International Journal of Epidemiology, Vol. 47, Núm. 2, pp. 473-483
2017
-
A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk
Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 28, Núm. 7, pp. 1618-1624
-
Reduced risk of pancreatic cancer associated with asthma and nasal allergies
Gut, Vol. 66, Núm. 2, pp. 314-322
2003
-
Doxorubicin in combination with fluorouracil and cyclophosphamide (i.v. FAC regimen, day 1, 21) versus methotrexate in combination with fluorouracil and cyclophosphamide (i.v. CMF regimen, day 1, 21) as adjuvant chemotherapy for operable breast cancer: A study by the GEICAM group
Annals of Oncology, Vol. 14, Núm. 6, pp. 833-842